Malec discusses the XTEND-ed trial, which proved the efficacy and tolerability of efanesoctocog alfa in adults and children with hemophilia A.
Lynn Malec, MD, MSc
Advertisement
Lynn Malec, MD, MSc, is an associate professor in the division of hematology and oncology at the Medical College of Wisconsin.
Articles by Lynn Malec, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
OMA 2026 Recap: Pediatrics, Retention, and Lifestyle Changes in Obesity
2
OMA 2026 Recap: GLP-1s in Conditions Beyond Obesity
3
OMA 2026 Recap: The Side Effects of GLP-1s for Obesity
4
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
5